Gevorg Tamamyan: We Can Do More…
FDA Approves Fam-Trastuzumab Deruxtecan-nxki With Pertuzumab for First-Line Treatment of HER2-Positive Metastatic Breast Cancer
How Sir Cliff Richard Beat Prostate Cancer at 85 and Why He’s Calling for National Screening
FDA Approves Niraparib Plus Abiraterone for BRCA2-Mutated Metastatic Castration-Sensitive Prostate Cancer
Servier Pharmaceuticals Welcomes Servier México Team to U.S. Office to Advance Strategic Alignment
SPCC Launches On Demand CME Webinars for the Definitive Trial Project
Ankyra Therapeutics Appoints Sailaja Battula, PhD, as Chief Scientific Officer
David OMalley: Promising Results From GOG 3026 Trial in Low-Grade Serous Ovarian Cancer
The ASYGO-ENYGO 1st Joint Webinar, titled "Training and Surgical Education in Gynecologic Oncology - Asia vs Europe," is a collaborative event between the Asian Society of Young Gynecologic Oncologists (ASYGO) and the European Network of Young Gynae Oncologists (ENYGO). Scheduled for Thursday, November 20, 2025, at 20:00 KST (Korean Standard Time) / 13:00 CET (Central […]
The SIOG 2025 Annual Conference will take place in person from 20 to 22 November 2025 at the International Convention Centre of Ghent (Gent ICC) in Belgium. This in-person event will bring together experts, researchers, and professionals in the field of geriatric oncology to share knowledge and discuss the latest advancements in the discipline. Remote participation […]
The ESO Refresher Course on Breast Cancer is a training program designed for medical, surgical, and radiation oncologists, pathologists, and radiologists involved in breast cancer management. Scheduled for November 21-23, 2025, in Sofia, Bulgaria, the course offers interactive, case-based sessions including tumor board discussions led by experts. It focuses on the latest diagnostic and therapeutic strategies, […]
The ESMO Advanced Course on ADC Development, Therapeutic Applications and Research in Breast Cancer 2025 will be held on 21–22 November 2025 in Barcelona, Spain. This course, chaired by Prof. Javier Cortés and Prof. Nadia Harbeck, provides an in-depth exploration of antibody-drug conjugates (ADCs), covering drug development, mechanisms of action, integration into clinical practice, and […]
The ESMO Advanced Course on Cholangiocarcinoma 2025 will be held on 21–22 November 2025 at the Hotel Barcelona Center in Barcelona, Spain. This course provides a comprehensive update on the diagnosis, molecular profiling, and management of cholangiocarcinoma, covering surgery, locoregional therapies, immunotherapy, targeted treatments, and both adjuvant and palliative strategies. Accredited with 11 ESMO-MORA points, […]
The IASLC 2025 Hot Topic in Basic and Translational Science: Unraveling Precancer and Early-Stage Lung Cancer meeting is a three-day event in Tokyo, Japan, dedicated to advancing the understanding and treatment of early lung cancer. Scheduled to begin on November 21, 2025, the meeting focuses on the molecular, genomic, transcriptomic, and immune mechanisms of early […]
The Hybrid Conference “Best of ESMO 2025,” an ESMO Licensed Event, will take place on 21 November at Radisson BLU Hotel Lietuva in Vilnius, Lithuania. Organized by the Lithuanian Society for Medical Oncology, the event offers both in-person and remote participation, with an 8-hour qualification certificate for all attendees. Registration is free but mandatory, and […]
The ECHoS Town Hall Meeting is a landmark event centered on the implementation of the Horizon Europe ECHoS project, which is dedicated to establishing national hubs across EU countries to […]
The Best of ESMO Gulf 2025, organized by the Emirates Oncology Society, will take place on 22–23 November 2025 at the Grand Plaza Mövenpick Media City, Dubai. This hybrid event brings together delegates, faculty, and industry partners to showcase the latest advancements in breast, gastrointestinal, genitourinary, and lung cancers, as presented at the ESMO 2025 […]
The 27th Annual Scientific Meeting of the Australasian Gastrointestinal Trials Group (AGITG) is a four-day conference focused on advancing GI cancer research through partnership. Held in Tarntanya/Adelaide from November 24–27, 2025, the event's theme is "Transforming Trials through Collaboration," highlighting the need for global cooperation and engagement with Aboriginal and Torres Strait Islander communities to […]
The London Global Cancer Week (LGCW) 2025 is a week-long series of multi-disciplinary, collaborative events scheduled from November 24 to 28, 2025, in London, UK. LGCW acts as a catalyst for change, convening professional bodies, universities, policy makers, private sector companies, and charities to focus on the global cancer challenge, particularly the disproportionate burden on […]
The LGCW 2025: Common Sense Oncology - Outcomes that Matter webinar is a virtual meeting scheduled for Monday, November 24th, 2025, from 6:00 PM to 7:00 PM GMT. The event is focused on the global Common Sense Oncology movement, which unites over 2,300 professionals and patient advocates to ensure cancer care and research prioritize outcomes […]